In conclusion, we demonstrated that P2X7 receptor is able to influence the entire TME purinergic signaling system modulating the secretion of ATP from both immune and tumor cells, but also acting via its degradation through ectonucleotidases expressed from different immune populations including Tregs, Teff, and cDC (Fig. 8). This evidence concerns the gene P2RX7 and neoplasm.